For more information or confidential assistance
800-306-3180
se habla español

Settlement Finalized for Androderm Testosterone Lawsuits

Hundreds of testosterone lawsuits have been officially resolved now that the master settlement agreement has been finalized, as of late July 2018. The settlement agreement only applies to Androderm lawsuits filed against Actavis and Allergan. Thousands of other testosterone lawsuits have been filed against other manufacturers in recent years. This... Read more »

500 Androderm Lawsuits May Be Resolved Soon

Byetta pancreatic cancer patient
Actavis, the makers of Androderm, has announced that there is a tentative settlement agreement in place that would resolve roughly 500 lawsuits. The plaintiffs involved with the litigation allege that they suffered serious complications as a result of their use of the defendants’ medicated testosterone patch. Actavis, which was acquired... Read more »

Androgel Bellwether Trial Ruling Favors Plaintiffs

Premises liability lawyer Los Angeles
In a case management order filed by US District Judge Matthew F. Kennelly, Androgel maker AbbVie was denied its attempt to have the first bellwether case dismissed on grounds that the statute of limitations had expired. The testosterone lawsuit, filed by Jeffrey Konrad, was originally selected as a representative case... Read more »

Studies Cast Doubt on Testosterone Therapy Benefits

Propecia erectile dysfunction patient
Testosterone supplementation for older men has become big business for companies like Abbott Laboratories and AbbVie as they have marketed their testosterone products to the general population. Unfortunately, the benefits touted by these manufacturers may be overstated, new studies are finding. In fact, the risks associated with testosterone therapy might... Read more »

Early Trials Selected for Growing Androgel Lawsuits

Eight Androgel lawsuits have been selected out of around 5,500 cases currently pending to serve as bellwether trials in the coordinated litigation. The bellwether trials are carefully selected to provide insight into how juries might respond to evidence and testimony in future trials. These early trials also can serve as... Read more »

Testosterone Claim Involving Testim Joins MDL 2545

Byetta pancreatic cancer patient
An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation in the Northern District of Illinois. According to his short form complaint, the man was prescribed and began taking Testim in June 2010. In... Read more »